surpass 2 tirzepatide Efficacy and safety of monotherapy compared with dulaglutide in Japanese patients with type diabetes (SURPASS J-mono): a double-blind, multicentre, randomised, phase 3 trial Tirzepatide versus Semaglutide in Type
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19


02188-7/asset/1f15c5ee-e9c1-4058-8e74-d7dafaec62ef/main.assets/gr2.jpg)






















